Tenaya Therapeutics, Inc.
NASDAQ:TNYA
Overview | Financials
Company Name | Tenaya Therapeutics, Inc. |
Symbol | TNYA |
Currency | USD |
Price | 1.47 |
Market Cap | 116,454,135 |
Dividend Yield | 0% |
52-week-range | 0.987 - 7.01 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Faraz Ali M.B.A. |
Website | https://www.tenayatherapeutics.com |
An error occurred while fetching data.
About Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD